BETTER/SMARTER.ME
Supporting Self-Enhancement Science for the Success of Society
Logo
The Institute for the Future of Human Potential
☰
VOLUME VIII | AUG 2017

New Drug May Slow Progression of Parkinson’s Disease

Dr. David Lowemann
Dr. David Lowemann
Dr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering

A new drug known as D-512 is being developed at New York’s Binghamton University to treat Parkinson’s disease. It promises to limit the progression of Parkinson’s disease while also relieving symptoms more effectively than drugs currently available.About 60,000 Americans…

Read Full Article (External Site)

Related posts:

  1. Good news for coffee drinkers large studies suggest it could reduce your risk of early death
  2. Chronic liver inflammation linked to Western diet
  3. Longer Looks: The Future Of Repeal; A New ‘War On Drugs’; And IVF Innovations
  4. Prosecutors To Be Deployed To Cities Ravaged By Opioid Epidemic To Crack Down On Fraud, Scams